Candida species
- SusceptibilityRepurposing of Ribavirin as an Adjunct Therapy against Invasive Candida Strains in an In Vitro Study
The use of antifungal agents in clinical settings is limited by the appearance of drug resistance and adverse side effects. There is, therefore, an urgent need to develop new drugs to strengthen the treatment of invasive fungal diseases. The aim of this study is to describe the potential repurposing of ribavirin as an adjunct therapy against Candida spp. Primary screening of a Prestwick Chemical library against...